92 related articles for article (PubMed ID: 9891500)
1. Dexamethasone enhances expression of membrane and soluble interleukin-6 receptors by prostate carcinoma cell lines.
Mori S; Murakami-Mori K; Bonavida B
Anticancer Res; 1998; 18(6A):4403-8. PubMed ID: 9891500
[TBL] [Abstract][Full Text] [Related]
2. Increased levels of plasma interleukin-6 soluble receptor in patients with essential thrombocythemia.
Marta R; Goette N; Lev P; Heller P; Kornblihtt L; Vassallú P; Glembotsky A; Pirola C; Molinas F
Haematologica; 2004 Jun; 89(6):657-63. PubMed ID: 15194532
[TBL] [Abstract][Full Text] [Related]
3. Characterization of TGF-beta-regulated interleukin-8 expression in human prostate cancer cells.
Lu S; Dong Z
Prostate; 2006 Jun; 66(9):996-1004. PubMed ID: 16541418
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer cells (LNCaP) generated after long-term interleukin 6 (IL-6) treatment express IL-6 and acquire an IL-6 partially resistant phenotype.
Hobisch A; Ramoner R; Fuchs D; Godoy-Tundidor S; Bartsch G; Klocker H; Culig Z
Clin Cancer Res; 2001 Sep; 7(9):2941-8. PubMed ID: 11555613
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the inflammatory network in benign prostate hyperplasia and prostate cancer.
König JE; Senge T; Allhoff EP; König W
Prostate; 2004 Feb; 58(2):121-9. PubMed ID: 14716737
[TBL] [Abstract][Full Text] [Related]
6. Expression of the matrix metalloproteinase promatrilysin in coculture of prostate carcinoma cell lines.
Stratton MS; Sirvent H; Udayakumar TS; Nagle RB; Bowden GT
Prostate; 2001 Aug; 48(3):206-9. PubMed ID: 11494336
[TBL] [Abstract][Full Text] [Related]
7. Regulation of interleukin-8 expression in human prostate cancer cells by insulin-like growth factor-I and inflammatory cytokines.
Kooijman R; Himpe E; Potikanond S; Coppens A
Growth Horm IGF Res; 2007 Oct; 17(5):383-91. PubMed ID: 17513150
[TBL] [Abstract][Full Text] [Related]
8. Oncostatin M (OM) promotes the growth of DU 145 human prostate cancer cells, but not PC-3 or LNCaP, through the signaling of the OM specific receptor.
Mori S; Murakami-Mori K; Bonavida B
Anticancer Res; 1999; 19(2A):1011-5. PubMed ID: 10368647
[TBL] [Abstract][Full Text] [Related]
9. Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate.
Steiner GE; Newman ME; Paikl D; Stix U; Memaran-Dagda N; Lee C; Marberger MJ
Prostate; 2003 Aug; 56(3):171-82. PubMed ID: 12772186
[TBL] [Abstract][Full Text] [Related]
10. Dexamethasone and cyclosporin A do not inhibit interleukin-15 expression in the human lung carcinoma cell line A549.
Stoeck M; Schäfer M; Hofmann HP; Gekeler V
Eur Cytokine Netw; 2000 Sep; 11(3):414-9. PubMed ID: 11022126
[TBL] [Abstract][Full Text] [Related]
11. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
Zerbini LF; Wang Y; Cho JY; Libermann TA
Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid induces expression of the interleukin-1beta gene in cultured normal human mammary epithelial cells and in human breast carcinoma lines.
Liu L; Gudas LJ
J Cell Physiol; 2002 Nov; 193(2):244-52. PubMed ID: 12385002
[TBL] [Abstract][Full Text] [Related]
13. DU-145 and PC-3 human prostate cancer cell lines express androgen receptor: implications for the androgen receptor functions and regulation.
Alimirah F; Chen J; Basrawala Z; Xin H; Choubey D
FEBS Lett; 2006 Apr; 580(9):2294-300. PubMed ID: 16580667
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression.
Lee SO; Chun JY; Nadiminty N; Lou W; Gao AC
Prostate; 2007 May; 67(7):764-73. PubMed ID: 17373716
[TBL] [Abstract][Full Text] [Related]
15. A novel human prostate-specific gene-1 (HPG-1): molecular cloning, sequencing, and its potential involvement in prostate carcinogenesis.
Herness EA; Naz RK
Cancer Res; 2003 Jan; 63(2):329-36. PubMed ID: 12543784
[TBL] [Abstract][Full Text] [Related]
16. INSL3 in the benign hyperplastic and neoplastic human prostate gland.
Klonisch T; Müller-Huesmann H; Riedel M; Kehlen A; Bialek J; Radestock Y; Holzhausen HJ; Steger K; Ludwig M; Weidner W; Hoang-Vu C; Hombach-Klonisch S
Int J Oncol; 2005 Aug; 27(2):307-15. PubMed ID: 16010410
[TBL] [Abstract][Full Text] [Related]
17. Expression of interleukin-6, interleukin-6 receptor, and glycoprotein 130 correlates with good prognoses for patients with breast carcinoma.
Karczewska A; Nawrocki S; Breborowicz D; Filas V; Mackiewicz A
Cancer; 2000 May; 88(9):2061-71. PubMed ID: 10813718
[TBL] [Abstract][Full Text] [Related]
18. Expression and up-regulation of interleukin-6 in oesophageal carcinoma cells by n-sodium butyrate.
Wang LS; Chow KC; Wu CW
Br J Cancer; 1999 Jul; 80(10):1617-22. PubMed ID: 10408408
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptors 2 and 4, and acute phase cytokine gene expression in dexamethasone and growth hormone treated dairy calves.
Eicher SD; McMunn KA; Hammon HM; Donkin SS
Vet Immunol Immunopathol; 2004 Apr; 98(3-4):115-25. PubMed ID: 15010221
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitro.
Okamoto M; Lee C; Oyasu R
Cancer Res; 1997 Jan; 57(1):141-6. PubMed ID: 8988055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]